Cargando…

Potential Benefit of Probiotic E. Coli Nissle in Term Neonates: A Multicentre Randomised Double Blind Controlled Trial

Background Probiotics are often viewed as an immunity enhancing agent. The objective of this study was to investigate whether oral administration of Escherichia coli Nissle 1917 reduces the number of infections, their duration, and severity in the first 24 months after parturition in healthy neonat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olbertz, Dirk, Proquitté, Hans, Patzer, Ludwig, Erler, Thomas, Mikolajczak, Alexsandra, Sadowska-Krawczenko, Iwona, Wolff, Corinna, Radke, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328724/ https://www.ncbi.nlm.nih.gov/pubmed/36446590 http://dx.doi.org/10.1055/a-1970-4340

Ejemplares similares

The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers
por: Henker, Jobst, et al.
Publicado: (2007)

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)
por: Matthes, Harald, et al.
Publicado: (2010)

Probiotic Properties of Escherichia coli Nissle in Human Intestinal Organoids
por: Pradhan, Suman, et al.
Publicado: (2020)

Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
por: Pérez-Berezo, Teresa, et al.
Publicado: (2017)

Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917
por: Massip, Clémence, et al.
Publicado: (2019)

Enhancing the antibacterial function of probiotic Escherichia coli Nissle: when less is more
por: Bartram, Emma, et al.
Publicado: (2023)

Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
por: Ukena, Sya N., et al.
Publicado: (2007)

The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ
por: Bury, Susanne, et al.
Publicado: (2018)

Transcriptional Profiling of the Probiotic Escherichia coli Nissle 1917 Strain under Simulated Microgravity
por: Yim, Jaewoo, et al.
Publicado: (2020)

Plasmid Vectors for in Vivo Selection-Free Use with the Probiotic E. coli Nissle 1917
por: Kan, Anton, et al.
Publicado: (2020)

Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity
por: Olier, Maïwenn, et al.
Publicado: (2012)

Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917
por: Dusek, Otakar, et al.
Publicado: (2020)

A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917
por: Nougayrède, Jean-Philippe, et al.
Publicado: (2021)

Efficient markerless integration of genes in the chromosome of probiotic E. coli Nissle 1917 by bacterial conjugation
por: Seco, Elena M., et al.
Publicado: (2021)

Serial passage in an insect host indicates genetic stability of the human probiotic Escherichia coli Nissle 1917
por: Schröder, Nicolas C H, et al.
Publicado: (2022)

Structural characterization of phosphoethanolamine-modified lipid A from probiotic Escherichia coli strain Nissle 1917
por: Jo, Sung-Hyun, et al.
Publicado: (2019)

Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota
por: Teng, Guigen, et al.
Publicado: (2022)

High-quality genome-scale metabolic network reconstruction of probiotic bacterium Escherichia coli Nissle 1917
por: van ‘t Hof, Max, et al.
Publicado: (2022)

Genetic circuits for feedback control of gamma-aminobutyric acid biosynthesis in probiotic Escherichia coli Nissle 1917
por: Lebovich, Matthew, et al.
Publicado: (2023)

A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome
por: Kruis, Wolfgang, et al.
Publicado: (2011)

An adult zebrafish model for adherent-invasive Escherichia coli indicates protection from AIEC infection by probiotic E. coli Nissle
por: Nag, Dhrubajyoti, et al.
Publicado: (2022)

Development of a Genome-Scale Metabolic Model and Phenome Analysis of the Probiotic Escherichia coli Strain Nissle 1917
por: Kim, Dohyeon, et al.
Publicado: (2021)

The host response to the probiotic Escherichia coli strain Nissle 1917: Specific up-regulation of the proinflammatory chemokine MCP-1
por: Ukena, Sya N, et al.
Publicado: (2005)

Administration of a Probiotic Can Change Drug Pharmacokinetics: Effect of E. coli Nissle 1917 on Amidarone Absorption in Rats
por: Matuskova, Zuzana, et al.
Publicado: (2014)

The secreted autotransporter toxin (Sat) does not act as a virulence factor in the probiotic Escherichia coli strain Nissle 1917
por: Toloza, Lorena, et al.
Publicado: (2015)

K5 Capsule and Lipopolysaccharide Are Important in Resistance to T4 Phage Attack in Probiotic E. coli Strain Nissle 1917
por: Soundararajan, Manonmani, et al.
Publicado: (2019)

Probiotic Escherichia coli Nissle 1917 protect chicks from damage caused by Salmonella enterica serovar Enteritidis colonization
por: Wu, Shu, et al.
Publicado: (2023)

Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy
por: Yu, Xiaoli, et al.
Publicado: (2019)

The probiotic strain Escherichia coli Nissle 1917 prevents papain-induced respiratory barrier injury and severe allergic inflammation in mice
por: Secher, Thomas, et al.
Publicado: (2018)

In Vitro Evaluation of the Impact of the Probiotic E. coli Nissle 1917 on Campylobacter jejuni’s Invasion and Intracellular Survival in Human Colonic Cells
por: Helmy, Yosra A., et al.
Publicado: (2017)

Immuno-modulatory effect of probiotic E. coli Nissle 1917 in polarized human colonic cells against Campylobacter jejuni infection
por: Helmy, Yosra A., et al.
Publicado: (2020)

Healthcare-associated infections in a neonatal intensive care unit
por: Sadowska-Krawczenko, Iwona, et al.
Publicado: (2012)

Colonization of Germ-Free Piglets with Commensal Lactobacillus amylovorus, Lactobacillus mucosae, and Probiotic E. coli Nissle 1917 and Their Interference with Salmonella Typhimurium
por: Splichal, Igor, et al.
Publicado: (2019)

Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages
por: Hu, Rujiu, et al.
Publicado: (2020)

Single domain antibodies against enteric pathogen virulence factors are active as curli fiber fusions on probiotic E. coli Nissle 1917
por: Gelfat, Ilia, et al.
Publicado: (2022)

Gradient Magnetic Field Accelerates Division of E. coli Nissle 1917
por: Gorobets, Svitlana, et al.
Publicado: (2023)

Impact of Escherichia coli probiotic strains ED1a and Nissle 1917 on the excretion and gut carriage of extended-spectrum beta-lactamase-producing E. coli in pigs
por: Mourand, Gwénaëlle, et al.
Publicado: (2021)

Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy
por: He, Lian, et al.
Publicado: (2019)

Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction
por: Secher, Thomas, et al.
Publicado: (2017)

CRISPRi-mediated suppression of E. coli Nissle 1917 virulence factors: A strategy for creating an engineered probiotic using csgD gene suppression
por: Azam, Mohd W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_10hqdgogqajr837c5q0catrc1t